|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 225.28 USD | +2.53% |
|
+2.89% | +0.92% |
| 01-14 | Veeva Systems Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 01:30 PM | |
| 01-08 | Veeva Systems, BioMarin Pharmaceutical Enter Long-Term Partnership | MT |
| Capitalization | 37.03B 31.52B 29.27B 27.44B 51.1B 3,392B 54.18B 334B 132B 1,602B 139B 136B 5,863B | P/E ratio 2026 * |
42.5x | P/E ratio 2027 * | 38x |
|---|---|---|---|---|---|
| Enterprise value | 30.39B 25.86B 24.02B 22.52B 41.93B 2,783B 44.46B 274B 109B 1,315B 114B 112B 4,811B | EV / Sales 2026 * |
9.58x | EV / Sales 2027 * | 8.07x |
| Free-Float |
90.83% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Veeva Systems Inc.
| 1 day | +2.53% | ||
| 1 week | +2.89% | ||
| Current month | +0.92% | ||
| 1 month | +0.86% | ||
| 3 months | -22.30% | ||
| 6 months | -21.01% | ||
| Current year | +0.92% |
| 1 week | 215.55 |  | 226.16 |
| 1 month | 215.55 | | 245.49 |
| Current year | 215.55 | | 245.49 |
| 1 year | 201.54 | | 310.5 |
| 3 years | 160.21 | | 310.5 |
| 5 years | 151.02 | | 343.96 |
| 10 years | 19.97 | | 343.96 |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Gassner
CEO | Chief Executive Officer | 61 | 12/01/2007 |
Tom Schwenger
PSD | President | 58 | 30/09/2019 |
| Director of Finance/CFO | 44 | 16/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Gassner
BRD | Director/Board Member | 61 | 04/08/2011 |
Matthew Wallach
BRD | Director/Board Member | 53 | 01/01/2020 |
Gordon Ritter
CHM | Chairman | 61 | 01/08/2008 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 2.37% | 1 M€ | |
| -4.34% | 2.36% | 4 M€ | |
| 0.00% | 2.34% | 54 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.53% | +2.89% | -1.65% | +38.69% | 37.03B | |
| +1.96% | -10.83% | -33.05% | +186.13% | 12.67B | |
| -0.80% | -3.30% | -10.82% | +35.95% | 4.8B | |
| +6.28% | +13.41% | - | - | 4.31B | |
| -0.15% | -7.25% | - | - | 2.85B | |
| -5.53% | -9.11% | - | - | 2.82B | |
| +1.66% | +0.67% | +20.41% | -8.36% | 2.3B | |
| +2.66% | -7.49% | +7.33% | - | 1.43B | |
| 0.00% | -9.18% | +34.93% | -40.32% | 1.25B | |
| Average | +0.96% | -2.77% | +2.86% | +42.42% | 7.72B | |
| Weighted average by Cap. | +1.92% | -1.32% | -7.24% | +67.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.17B 2.7B 2.51B 2.35B 4.38B 291B 4.64B 28.63B 11.34B 137B 11.9B 11.65B 502B | 3.56B 3.03B 2.81B 2.64B 4.91B 326B 5.2B 32.1B 12.72B 154B 13.34B 13.06B 563B |
| Net income | 895M 762M 707M 663M 1.24B 81.97B 1.31B 8.08B 3.2B 38.72B 3.36B 3.29B 142B | 1.02B 867M 805M 755M 1.41B 93.33B 1.49B 9.2B 3.64B 44.09B 3.82B 3.74B 161B |
| Net Debt | -6.65B -5.66B -5.25B -4.93B -9.17B -609B -9.72B -59.98B -23.77B -288B -24.92B -24.41B -1,052B | -8.32B -7.08B -6.57B -6.16B -11.48B -762B -12.17B -75.06B -29.74B -360B -31.19B -30.55B -1,317B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/01/26 | 225.28 $ | +2.53% | 1,475,531 |
| 21/01/26 | 219.73 $ | +1.60% | 2,032,211 |
| 20/01/26 | 216.26 $ | -2.68% | 1,683,506 |
| 16/01/26 | 222.21 $ | +1.49% | 2,625,745 |
| 15/01/26 | 218.95 $ | +0.04% | 2,678,043 |
Delayed Quote Nyse, January 23, 2026 at 01:00 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VEEV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition